Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.

Also called NCT02673164

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 133 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02673164
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02673164. Randomized; quadruple masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2020-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease
Acronym
SCIENCE
Condition
Heart Failure
Intervention (Biological)
CSCC_ASC
Lead sponsor
JKastrup (class: other)
Collaborator
European Union (class: other)

Record details

Record id
cardio:ct-nct02673164
Content hash
44855720156899bb6d1993bf7582430ce10781d3258f564d564906ea20d1d21c